NIH's Environmental Health Meeting: Part Open, Part Secret Science
Published Date: 12/22/2025
Notice
Summary
The National Institute of Environmental Health Sciences is holding a partly open meeting on March 18, 2026, where some sessions will be public and others private to protect sensitive info. Scientists, grant applicants, and the public are affected, with virtual access available for open parts. This meeting helps decide on research projects and funding, but no direct money changes are announced yet.
Analyzed Economic Effects
4 provisions identified: 3 benefits, 0 costs, 1 mixed.
Open Sessions Are Virtual and Videocast
You can watch or attend the open parts of the NIEHS advisory council meeting on March 18, 2026. Open sessions are scheduled on that day at 9:00–11:00 a.m., 11:15 a.m.–12:00 p.m., and 12:45–2:15 p.m., are videocast on the NIH/NIEHS webcasts site, and registration is not required. If you need special assistance (for example, sign language), you must notify the contact person in advance.
Certain Sessions Closed to Protect Confidentiality
Part of the March 18, 2026 meeting (2:45–5:00 p.m.) will be closed to the public under 5 U.S.C. 552b(c)(4) and (c)(6) to protect confidential trade secrets, patentable material, commercial property, and personal information in grant applications and contract proposals. Scientists and grant applicants should expect that discussions of intramural reports and grant applications will occur in private.
How to Submit Written or Oral Comments
Any interested person may file written comments for the committee or request to present oral comments for the March 18, 2026 meeting by contacting the listed Contact Person. To present oral comments you must notify the Contact Person at least 10 days before the meeting; presentations may be limited to five minutes and only one representative per organization may present. Both printed and electronic copies of comments are requested for the record.
Meeting Reviews Research Projects and Funding
The council meeting on March 18, 2026 will review intramural reports and consider grant applications and contract proposals, which helps decide research projects and future funding. The notice states that no direct changes to funding amounts are announced in this notice.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-16683, Proposed Collection; 60-Day Comment Request; Data Use Certification for the NIH National Institute on Drug Abuse Data Share Site
The purpose of this notice is to inform the public of the information collection requirement for the NIDA Data Share, the data use terms and conditions, and to request a progress report statement at the time of renewal. In compliance with the requirement of the Paperwork Reduction Act of 1995 to provide opportunity for public comment on proposed data collection projects, the National Institute on Drug Abuse (NIDA) will publish periodic summaries of proposed projects to be submitted to the Office of Management and Budget (OMB) for review and approval.
2026-16544, Government-Owned Inventions; Availability for Licensing
The inventions listed below are owned by an agency of the U.S. Government and are available for licensing to achieve expeditious commercialization of results of federally-funded research for the benefit of the public health.
2026-16440, NIH Owned Invention Available for License: Soluble Tissue Factor, a Novel Target, and Antibodies, for Diagnosis, Prevention and Treatment of Thrombosis and Related Conditions
Scientists at the National Cancer Institute (NCI) have discovered a novel therapeutic, diagnostic and prognostic target for thrombosis: Soluble Tissue Factor (sTF). NCI has generated first-in- class antibodies and platform selectively neutralizing pathological coagulation while preserving normal hemostasis. This platform technology can be used to prevent, diagnose and treat pathological thrombosis caused by a variety of clinical conditions-including cancer, sepsis, infectious diseases (e.g., COVID), autoimmune disorders, trauma, heart conditions and inflammatory conditions. It offers a much more sensitive and specific test of thrombosis than the current D-dimer test. It may be applicable to any clinical condition which induces necroptosis, pyroptosis and NETtosis, such as cancer, neurodegenerative disease, ischemia-reperfusion and acute injuries, traumatic injuries, bacterial and viral infections, cardiovascular conditions, and atherosclerosis, inflammatory, autoimmune conditions, and others.
2026-16071, Proposed Collection; 60-Day Comment Request: The Impact of Clinical Research Training and Medical Education at the Clinical Center on Physician Careers in Academia and Clinical Research (Clinical Center)
In compliance with the requirement of the Paperwork Reduction Act of 1995, for opportunity for public comment on proposed data collection projects, the Clinical Center, the National Institutes of Health (NIH) will publish periodic summaries of proposed projects to be submitted to the Office of Management and Budget (OMB) for review and approval.
2026-15565, Proposed Collection; 60-Day Comment Request, Data Use Certification for the NIH Brain Development Cohorts (NBDC) Data Hub, (National Institute on Drug Abuse)
In compliance with the requirement of the Paperwork Reduction Act of 1995 to provide opportunity for public comment on proposed data collection projects, the National Institute on Drug Abuse (NIDA) will publish periodic summaries of proposed projects to be submitted to the Office of Management and Budget (OMB) for review and approval. The purpose of this revision is to update instructions for the Research Data Use Statement and the Progress Report, and to add new instructions for attesting to National Institute of Standards & Technology (NIST) security compliance, and for a Project Close-out at the time of project completion. Burden levels remain unchanged.
2026-14964, Center for Scientific Review; Notice of Closed Meeting
The Center for Scientific Review is holding a closed virtual meeting on August 19, 2026, to review neuroscience career development grant applications. This meeting is private to protect sensitive info like trade secrets and personal details. Researchers applying for these grants should note the date, as funding decisions could impact their projects and careers.
Previous / Next Documents
Previous: 2025-23498, Certain Softwood Lumber Products From Canada: Final Results of Antidumping Duty Administrative Review; 2019; Correction
The U.S. Department of Commerce fixed a mistake from 2021 by adding three Canadian lumber companies they accidentally left out of an important trade review. This correction makes sure the right companies are included in the 2019 antidumping duty results, which could affect how duties are applied and money is handled. If you’re involved with these companies or lumber trade, this update keeps everything fair and square.
Next: 2025-23500, National Library of Medicine; Notice of Partially Closed Meeting
The National Library of Medicine’s Board of Regents will hold a virtual meeting on February 9-10, 2026, with some parts open to the public and others closed to protect private info and trade secrets. They’ll review grant applications and discuss programs, affecting researchers and the public interested in medical info. No registration is needed to watch, and you can send comments up to 15 days before the meeting.